Ken Valenzano, VP, Pharmacology & Biology at AMICUS THERAPEUTICS INC (FOLD), bought 12,450 shares at $6.00 ($75K) on 2014-08-25, disclosed to the SEC on 2014-08-26.
Scheduled purchase ($75k) by VP, Pharmacology & Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 5,000 | $30K | 40.2% |
| 2 | $6.00 | 7,450 | $45K | 59.8% |
| Total | $6.00 avg | 12,450 | $75K | 100% |
| Filing → |
| FOLD | SELL | 2015-05-12 | $141K | — | Filing → |
| FOLD | SELL | 2015-04-17 | $63K | — | Filing → |
| FOLD | SELL | 2015-03-25 | $91K | — | Filing → |